Genetic and pharmacological interrogation of cancer vulnerability using a multiplexed cell line screening platform
Xia et al. report the development and optimization of a high-throughput screening platform to systematically determine cancer cell sensitivity to pharmacological and genetic perturbations, BMS-PRISM, based on PRISM and high-throughput CRISPR/Cas9 loss-of-function screen technologies using cell line...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Nature Portfolio
2021
|
| Subjects: | |
| Online Access: | https://doaj.org/article/4d8d29c70bdc4a77a7632fc27bcf2dfd |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|